BR100 Decreased By (-0.25%)
BR30 Decreased By (-0.64%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.83 Decreased By ▼ -0.20 (-3.32%)
BML 57.90 Increased By ▲ 5.15 (9.76%)
BOP 33.79 Decreased By ▼ -0.46 (-1.34%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.79 Decreased By ▼ -0.55 (-4.46%)
FCCL 53.49 Decreased By ▼ -0.40 (-0.74%)
FCSC 5.40 Increased By ▲ 0.18 (3.45%)
FFL 17.84 Decreased By ▼ -0.19 (-1.05%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.11 Increased By ▲ 0.11 (1%)
KEL 8.02 Decreased By ▼ -0.09 (-1.11%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.40 Decreased By ▼ -0.65 (-0.74%)
NBP 184.24 Decreased By ▼ -2.24 (-1.2%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.25 Increased By ▲ 0.31 (0.78%)
PIAHCLA 26.12 Decreased By ▼ -0.05 (-0.19%)
PIBTL 17.14 Decreased By ▼ -0.18 (-1.04%)
PPL 228.73 Decreased By ▼ -4.05 (-1.74%)
PRL 34.49 Decreased By ▼ -0.46 (-1.32%)
PTC 67.54 Decreased By ▼ -0.02 (-0.03%)
SEARL 90.93 No Change ▼ 0.00 (0%)
SSGC 26.83 Decreased By ▼ -0.34 (-1.25%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.33 Increased By ▲ 0.57 (6.51%)
TREET 24.51 Decreased By ▼ -0.03 (-0.12%)
TRG 71.61 Decreased By ▼ -0.14 (-0.2%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
Business & Finance

DRAP, WHO to boost cooperation in health sector

ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) and World Health Organization have agreed to boost the mutua
Published February 20, 2018 Updated February 20, 2018 09:18pm

ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) and World Health Organization have agreed to boost the mutual cooperation between two organizations in health sector.

This decision was taken in a meeting between Dr Sheikh Akhter Hussain CEO, DRAP and Dr. Muhammad Assai, WHO Representative for Pakistan.

DRAP and WHO mutually agreed on the exchange of information, knowledge, education and training with the shared objective of achieving universal health.

The WHO Representative recognized that both organizations have a number of common interests. CEO DRAP thanked the WHO for its continued support in the past.

WHO and DRAP wish to work together more closely to better serve the people of Pakistan with the common goal of improving the health and provision of safe, quality and efficacious medicines.

Both sides discussed matters of mutual interest including effective implementation of DRAP Act, 2012 and issues regarding availability of therapeutic goods.

WHO Representative assured DRAP that his organization will work alongside by DRAP and increase its cooperation for improvement in quality of medicines. He appreciated the commitment shown by DRAP in performing its duties for betterment of ailing masses.

WHO pledged its support to DRAP for enhancement of capacity building, stream lining process of collaborative registration with other WHO member countries and accreditation of DRAP as National Regulatory Authority (NRA).

Copyright APP (Associated Press of Pakistan), 2018

Comments

Comments are closed for this article.